Literature DB >> 9280831

Valvular heart disease associated with dexfenfluramine.

L B Cannistra, S M Davis, A G Bauman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9280831     DOI： 10.1056/nejm199708283370912

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  A risk-benefit assessment of anti-obesity drugs.

Authors:  J Kolanowski
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 2.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Cerivastatin, genetic variants, and the risk of rhabdomyolysis.

Authors:  Kristin D Marciante; Jon P Durda; Susan R Heckbert; Thomas Lumley; Ken Rice; Barbara McKnight; Rheem A Totah; Bani Tamraz; Deanna L Kroetz; Hisayo Fukushima; Rüdiger Kaspera; Joshua C Bis; Nicole L Glazer; Guo Li; Thomas R Austin; Kent D Taylor; Jerome I Rotter; Cashell E Jaquish; Pui-Yan Kwok; Russell P Tracy; Bruce M Psaty
Journal:  Pharmacogenet Genomics       Date:  2011-05       Impact factor: 2.089

4.  Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs.

Authors:  S Rajamani; C Studenik; R Lemmens-Gruber; P Heistracher
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 5.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

Review 6.  Toward a broader view of mechanisms of drug cardiotoxicity.

Authors:  Polina Mamoshina; Blanca Rodriguez; Alfonso Bueno-Orovio
Journal:  Cell Rep Med       Date:  2021-03-16

Review 7.  Anti-obesity drug discovery: advances and challenges.

Authors:  Timo D Müller; Matthias Blüher; Matthias H Tschöp; Richard D DiMarchi
Journal:  Nat Rev Drug Discov       Date:  2021-11-23       Impact factor: 112.288

Review 8.  Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies.

Authors:  Munazza Tamkeen Fatima; Ikhlak Ahmed; Khalid Adnan Fakhro; Ammira Sarah Al-Shabeeb Akil
Journal:  Diabetes Obes Metab       Date:  2022-01-11       Impact factor: 6.408
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.